Identification of distinct gene expression profiles in the synovium of patients with systemic lupus erythematosus

Arthritis and Rheumatism

Volumn 56, Issue 5, 2007, Pages 1579-1588

  Nzeusseu Toukap, A ^a   Galant, C ^a   Theate, I ^a   Maudoux, A L ^a   Lories, R J U ^b   Houssiau, F A ^a   Lauwerys, B R ^a,b,c  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; INTERFERON INDUCIBLE PROTEIN 27; INTERFERON INDUCIBLE PROTEIN 44; INTERFERON INDUCIBLE PROTEIN 44 LIGAND; PROTEIN DERIVATIVE; PROTEOCHONDROITIN SULFATE; SEPRASE; TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN 2; UNCLASSIFIED DRUG;

ARTICLE; DOWN REGULATION; EXTRACELLULAR MATRIX; GENE AMPLIFICATION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; HYBRIDIZATION; IMMUNOHISTOCHEMISTRY; JOINT BIOPSY; JOINT SWELLING; KNEE ARTHROSCOPY; MICROARRAY ANALYSIS; NEEDLE BIOPSY; NUCLEOTIDE SEQUENCE; OSTEOARTHRITIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; SYNOVIUM; SYSTEMIC LUPUS ERYTHEMATOSUS; UNINDEXED SEQUENCE; UPREGULATION;

ADULT; AGED; ANTIGENS; ANTIGENS, NEOPLASM; ARTHRITIS, RHEUMATOID; BIOPSY; CYTOSKELETAL PROTEINS; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; HUMANS; LATENT TGF-BETA BINDING PROTEINS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MEMBRANE PROTEINS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOARTHRITIS, KNEE; SERINE ENDOPEPTIDASES; SYNOVIAL MEMBRANE; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION; VERSICANS;

EID: 34248584526     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.22578     Document Type: Article

References (14)

1. Richter Cohen M, Steiner G, Smolen JS, Isenberg DA. Erosive arthritis in systemic lupus erythematosus: analysis of a distinct clinical and serological subset. Br J Rheumatol 1998;37:421-4.
2. Mediwake R, Isenberg DA, Schellekens GA, van Venrooij WJ. Use of anti-citrullinated peptide and anti-RA33 antibodies in distinguishing erosive arthritis in patients with systemic lupus erythematosus and rheumatoid arthritis. Ann Rheum Dis 2001;60: 67-8.
3. Ostendorf B, Scherer A, Specker C, Modder U, Schneider M. Jaccoud's arthropathy in systemic lupus erythematosus: differentiation of deforming and erosive patterns by magnetic resonance imaging. Arthritis Rheum 2003;48:157-65.
4. Natour J, Montezzo LC, Moura LA, Atra E. A study of synovial membrane of patients with systemic lupus erythematosus (SLE). Clin Exp Rheumatol 1991;9:221-5.
5. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
6. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
7. Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44-8.
8. Beissbarth T, Speed TP. Gostat: find statistically overrepresented gene ontologies within a group of genes. Bioinformatics 2004;20: 1464-5.
9. Bennett L, Palucka AK, Arce E, Cantrell V, Borvak J, Banchereau J, et al. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 2003;197: 711-23.
10. Baechler EC, Batliwalla FM, Karypis G, Gaffney PM, Ortmann WA, Espe KJ, et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A 2003;100:2610-5.
11. Coclet-Ninin J, Dayer JM, Burger D. Interferon-β not only inhibits interleukin-1β and tumor necrosis factor-α but stimulates interleukin-1 receptor antagonist production in human peripheral blood mononuclear cells. Eur Cytokine Netw 1997; 8:345-9.
12. Ozenci V, Kouwenhoven M, Huang YM, Kivisakk P, Link H. Multiple sclerosis is associated with an imbalance between tumour necrosis factor-α (TNF-α)- and IL-10-secreting blood cells that is corrected by interferon-β (IFN-β) treatment. Clin Exp Immunol 2000;120:147-53.
13. Palucka AK, Blanck JP, Bennett L, Pascual V, Banchereau J. Cross-regulation of TNF and IFN-α in autoimmune diseases. Proc Natl Acad Sci U S A 2005;102:3372-7.
14. Milner JM, Kevorkian L, Young DA, Jones D, Wait R, Donell ST, et al. Fibroblast activation protein α is expressed by chondrocytes following a pro-inflammatory stimulus and is elevated in osteoarthritis. Arthritis Res Ther 2006;8:R23.